HARMONYC Trademark

Trademark Overview


On Wednesday, March 29, 2023, a trademark application was filed for HARMONYC with the United States Patent and Trademark Office. The USPTO has given the HARMONYC trademark a serial number of 97862536. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, January 2, 2024. This trademark is owned by BGB Communications, LLC. The HARMONYC trademark is filed in the Advertising, Business and Retail Services category with the following description:

Advertising agencies specializing in pharmaceutical branding, product launch and consulting; Advertising and marketing consultancy; Advertising and publicity services, namely, promoting the goods, services, brand identity and commercial information and news of third parties through digital technology, video, and live events; Advertising consultation; Advertising services in the field of pharmaceuticals; Advertising services, namely, creating corporate and brand identity for others; Advertising services, namely, promoting and marketing the goods and services of others in the field of pharmaceuticals via print and electronic media; Advertising, marketing and promotion services in the field of pharmaceuticals; Brand concept and brand development services for corporate clients; Business consultation in the field of pharmaceuticals; Concept and brand development in the pharmaceuticals; Concept and brand development services for corporate clients; Conducting market surveys; Digital advertisi...
harmonyc

General Information


Serial Number97862536
Word MarkHARMONYC
Filing DateWednesday, March 29, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, January 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAdvertising agencies specializing in pharmaceutical branding, product launch and consulting; Advertising and marketing consultancy; Advertising and publicity services, namely, promoting the goods, services, brand identity and commercial information and news of third parties through digital technology, video, and live events; Advertising consultation; Advertising services in the field of pharmaceuticals; Advertising services, namely, creating corporate and brand identity for others; Advertising services, namely, promoting and marketing the goods and services of others in the field of pharmaceuticals via print and electronic media; Advertising, marketing and promotion services in the field of pharmaceuticals; Brand concept and brand development services for corporate clients; Business consultation in the field of pharmaceuticals; Concept and brand development in the pharmaceuticals; Concept and brand development services for corporate clients; Conducting market surveys; Digital advertising services; Market analysis and research services; Marketing consultation in the field of pharmaceuticals; Marketing consulting; Marketing plan development; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry; Providing advertising, marketing and promotional services for the pharmaceutical and medical products of others

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, April 20, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBGB Communications, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10013

Trademark Events


Event DateEvent Description
Tuesday, April 2, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, April 2, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, January 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 2, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 2, 2024NON-FINAL ACTION WRITTEN
Friday, December 22, 2023ASSIGNED TO EXAMINER
Thursday, April 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 1, 2023NEW APPLICATION ENTERED